Gene patents in the US - focusing on what really matters

With new technologies, concerns about gene patent claims regarding isolated DNA are becoming less relevant, but broad method claims could be more problematic.

Detalles Bibliográficos
Autores principales: Dobson, Allison W, Evans, James P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446309/
https://www.ncbi.nlm.nih.gov/pubmed/22748211
http://dx.doi.org/10.1186/gb-2012-13-6-161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446309/
https://www.ncbi.nlm.nih.gov/pubmed/22748211
http://dx.doi.org/10.1186/gb-2012-13-6-161

Ejemplares similares